InsiderClue
Insiders · Profile

CLARKE JOHN K

Director at aTYR PHARMA · Director at ALNYLAM PHARMACEUTICALS · Director at Verastem. Filing since 1 Feb 2012. CIK 0001219015

ATYR aTYR PHARMA INC Director · 5 trades ALNY ALNYLAM PHARMACEUTICALS, INC. Director · 2 trades VSTM Verastem, Inc. Director · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ATYR aTYR PHARMA INC
21 May 2021
Director
Sold, plan not stated
2,500
$10.85K
2.3%
ATYR aTYR PHARMA INC
2 Sep 2020
Director
Sold, plan not stated
7,260
$29.11K
6.2%
ATYR aTYR PHARMA INC
28 Aug 2020
Director
Sold, plan not stated
100
$400.00
0.1%
ATYR aTYR PHARMA INC
27 Aug 2020
Director
Sold, plan not stated
5,440
$22.25K
4.4%
ATYR aTYR PHARMA INC
26 Aug 2020
Director
Sold, plan not stated
2,200
$9.45K
1.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
31 May 2018
Director
Sold, plan not stated
15,000
$1.50M
62.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
21 May 2014
Director
Sold, plan not stated
35,000
$1.88M
100%
VSTM Verastem, Inc.
12 Jun 2013
Director
Bought
23,171
$222.43K
1.0%
VSTM Verastem, Inc.
11 Jun 2013
Director
Bought
25,000
$230.48K
1.1%
VSTM Verastem, Inc.
13 May 2013
Director
Bought
25,000
$243.38K
1.1%
VSTM Verastem, Inc.
1 May 2013
Director
Bought
10,000
$96.62K
0.4%
VSTM Verastem, Inc.
17 Apr 2013
Director
Bought
5,631
$53.49K
0.3%
VSTM Verastem, Inc.
18 Dec 2012
Director
Bought
6,193
$48.74K
0.3%
VSTM Verastem, Inc.
1 Feb 2012
Director
Bought
250,000
$2.50M
12.6%
14 decisions on file.